Topical clotrimazole: Phase I/II trial

Ion Pharmaceuticals Inc., New York, N.Y. Product: Topical clotrimazole Indication: Actinic keratosis Status: Ion, a subsidiary of Sheffield Medical Technologies Inc. (SHM, New York, N.Y.), began a Pha...